Monitoring

Retesting serum 25-hydroxyvitamin D concentrations (e.g., after 2-3 months) is typical to assess effectiveness and adjust doses as needed. The optimal treatment target is debated, but many guidelines and experts recommend a goal of reaching and maintaining a serum 25-hydroxyvitamin D concentration of at least 30 nanograms/mL, particularly in older adults.[118][119][83][84]​ The patient should then be started on daily maintenance vitamin D therapy. Once taking maintenance doses of vitamin D, the serum 25-hydroxyvitamin D level is typically measured annually.

In addition to the above, patients with osteomalacia should have serum phosphate, calcium, creatinine, albumin, and parathyroid hormone levels measured on an annual basis. Bone density monitoring is also recommended. Similarly, patients with rickets require careful monitoring of serum calcium, phosphate, albumin, 25-hydroxyvitamin D, and alkaline phosphatase levels. Monitoring of the urine can detect changes in calcium and phosphorus. Abnormal fluctuations in serum or urine values may require adjustment to the dose.

Use of this content is subject to our disclaimer